lung cancer
Entity, reached from Hormuz.
- Evidence
- 303 documents · 89 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 26 Mar 2026, last seen 8 Oct 2026
- Measured
- 18% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- medRxiv Oncology · 2026-10-07 · Prior immune checkpoint inhibitor exposure, treatment interval, and severe hepatotoxicity with sotorasib in KRAS G12C-mutant non-small-cell lung cancer: a systematic r… (opens the source in a new tab)
- Endpoints News · 2026-10-07 · ArriVent's lung cancer drug firmonertinib fails key late-stage trial, stock tanks (opens the source in a new tab)
- The Well News · 2026-10-07 · Amid Navy Celebration, Don’t Overlook Lung Cancer Screening for Asbestos-Exposed Veterans (opens the source in a new tab)
- Latest Science News -- ScienceDaily · 2026-10-06 · Scientists just found a way to fight lung cancer and muscle wasting at the same time (opens the source in a new tab)
- Fierce Biotech · 2026-10-06 · ArriVent’s phase 3 lung cancer trial flops, sinking stock (opens the source in a new tab)
- Proc Natl Acad Sci U S A · 2026-10-05 · Chronic cigarette smoke exposure induces distinct stem cell states driving genetic driver-specific non-small cell lung cancer subtypes. (opens the source in a new tab)
- Inside Precision Medicine · 2026-10-03 · Plasma Epigenomic Profiling May Enable Noninvasive Subtyping of Small-Cell Lung Cancer (opens the source in a new tab)
- European Medical Journal · 2026-10-02 · Radiomic Body Composition Improves Lung Cancer Survival Prediction (opens the source in a new tab)
- The ASCO Post · 2026-10-02 · Annual Report to the Nation: Progress Against Lung Cancer Drives Down Cancer Mortality (opens the source in a new tab)
- The ASCO Post · 2026-10-02 · Advanced Lung Cancer Pumitamig Plus Elfetabart Drozuntecan (opens the source in a new tab)
2 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with immunotherapy (90 documents)seen together
- co-mentioned with kras (82 documents)seen together
- co-mentioned with fda (69 documents)seen together
- co-mentioned with studie (67 documents)seen together
- co-mentioned with egfr (63 documents)seen together
- co-mentioned with colorectal cancer (56 documents)seen together
- co-mentioned with china (55 documents)seen together
- co-mentioned with ai (54 documents)seen together
- co-mentioned with breast cancer (53 documents)seen together
- co-mentioned with her2 (33 documents)seen together